Evolv Technologies Holdings, Inc.
NASDAQEVLV reports Q1 2026 results today against a backdrop of persistent insider selling — a pattern that has run for months and now sits directly in the market's line of sight. Founder and Director Michael Ellenbogen has sold shares every month since at least March, offloading roughly 80,000–92,000 shares per tranche at prices ranging from $5.10 to $6.32. CFO George Kutsor followed…
EVLV cost to borrow surges to 1.20% from 0.48% in one week, a 235% spike amid declining short interest.
Snapshot as of 22 Jun 2026
EVLV reports Q1 2026 results today against a backdrop of persistent insider selling — a pattern that has run for months and now sits directly in the market's line of sight. Founder and Director Michael Ellenbogen has…
Evolv Technologies heads into tomorrow's Q1 earnings report with a story split squarely between accelerating revenue momentum and a steady drip of insider disposals from the company's own founders. The most telling…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for EVLV — free to start on ORTEX.
Sign up for free →Open EVLV on ORTEX